Elsevier

Clinical Breast Cancer

Volume 11, Issue 6, December 2011, Pages 364-368
Clinical Breast Cancer

Original study
Stress Management and Resilience Training (SMART) Program to Decrease Stress and Enhance Resilience Among Breast Cancer Survivors: A Pilot Randomized Clinical Trial

https://doi.org/10.1016/j.clbc.2011.06.008Get rights and content

Abstract

Introduction

Patients with breast cancer experience stress and anxiety related to their diagnosis, with resulting lower quality of life. The purpose of this study was to assess the effect of a SMART (Stress Management and Resiliency Training) program for increasing resiliency and for decreasing stress and anxiety among mentors who themselves were previously diagnosed with breast cancer.

Materials and Methods

The program consisted of two 90-minute group training sessions, a brief individual session, and 3 follow-up telephone calls. Twenty-four mentors at Mayo Clinic in Rochester, Minnesota, were randomized in a single-blind, wait-list controlled clinical trial to either the SMART intervention or a control group for 12 weeks. Primary outcome measures assessed at baseline and at week 12 included the Connor Davidson Resilience Scale, Perceived Stress Scale, Smith Anxiety Scale, and Linear Analog Self Assessment Scale.

Results

Twenty patients completed the study. A statistically significant improvement in resilience, perceived stress, anxiety, and overall quality of life at 12 weeks, compared with baseline was observed in the study arm. No significant difference in any of these measures was noted in the control group.

Conclusion

This study demonstrates that a brief, predominantly group-based resilience training intervention is feasible in patients with previous breast cancer; also, it may be efficacious.

Introduction

Breast cancer is the most common cancer among women and the most common cause of cancer death in women worldwide and in developed countries.1 Patients diagnosed with breast cancer experience considerable stress, anxiety, fear, and depression.2 The emotional response to breast cancer may be independent of disease stage, because women diagnosed with noninvasive breast cancers also experience powerful emotions.2 The emotional impact of a cancer diagnosis and the rigors of cancer treatment adversely affect quality of life (QOL), and this may persist beyond treatment.3

One possible source of support for patients with newly diagnosed breast cancer is from women who have themselves coped with breast cancer. These breast cancer survivors can serve as mentors to provide newly diagnosed patients with first-hand information about what to expect from prescribed cancer treatment, to present coping strategies, provide encouragement, and to offer ways to actively combat barriers to personal recovery. A one-on-one peer mentorship program, the Pink Ribbon Mentorship Program, was developed to provide support to patients with newly diagnosed breast cancer who were receiving care at Mayo Clinic in Rochester, Minnesota. This Pink Ribbon Mentorship Program started offering support to breast cancer patients in December 2006. The mentors who provide support to the patients with newly diagnosed breast cancer themselves have to face the stress of a previous cancer diagnosis. Thus, improving their stress-managing ability might be an optimal strategy to improve their well-being. A key component of this approach is to enhance resilience.

Resilience refers to the ability to thrive despite stress and adversity.4 Resilience also is described as invulnerability and hardiness.5 The source of resilience is an individual's innate strength that helps the individual adapt to stressors and pursue life's meaning and purpose. Resilience correlates with positive physical and mental health in several studies.6, 7, 8, 9 In terms of brain function, resilience correlates with higher activation of the prefrontal cortex and lower activation of the limbic system, particularly the amygdala.10, 11, 12 Results from a few studies support that individual resilience can be increased by training and that this might have a positive effect on clinically meaningful outcomes.6, 7, 8, 9 Resilience training thus offers a feasible and potentially useful intervention to promote patient well-being. The present study was designed to test a Stress Management and Resiliency Training (SMART) program for enhancing resilience and well-being and for decreasing stress and anxiety among Pink Ribbon Mentors.

Section snippets

Study Design and Population

The Mayo Foundation Institutional Review Board reviewed and approved the study protocol before recruitment and enrollment. The study was designed as a randomized, wait-list controlled, pilot clinical trial that enrolled 25 Pink Ribbon Mentors at Mayo Clinic in Rochester, Minnesota. Inclusion criteria were the following (1) being a Pink Ribbon Mentor; (2) able and willing to participate in all aspects of the study; and (3) provided with, understood, and signed the appropriate informed consent

Demographics

Patient demographics are presented in Table 1. Of the 24 mentors enrolled, 20 (83%) completed the study. One participant was excluded before randomization, and 4 participants declined to participate after randomization due to personal issues (Figure 1). The ages of the 20 patients ranged from 46 to 75 years. Eleven subjects in the active arm participated in the additional one-on-one 30-minute individualized session with a study investigator (K.P.).

Telephone Calls

Of the 12 subjects in the intervention arm, 4

Discussion

This pilot study demonstrates that a brief training in resilience when using the SMART program is feasible. Results of the study also suggest that the intervention has a potential to improve resiliency, stress, anxiety, QOL, and fatigue. The brief duration of the training is a particularly appealing aspect of the intervention. Several other studies have evaluated the effects of programs to improve QOL in breast cancer survivors. A randomized controlled trial of 256 breast cancer survivors who

Conclusion

Brief training in resilience by using the SMART program for breast cancer survivors is feasible. Such an intervention has a potential to improve self-reported measures of resilience, QOL, stress, and anxiety, at least for the short term. Larger clinical trials with a longer duration of follow-up with this intervention are warranted.

Disclosure

The authors have no disclosures. The study was funded by the Sponsorship Research Committee, Mayo Clinic College of Medicine.

References (21)

There are more references available in the full text version of this article.

Cited by (218)

View all citing articles on Scopus
View full text